Abstract
Malignant giant cell tumor (MGCT) in the spine is extremely rare and there is little published information regarding this subject in the literature. We attempted to correlate different treatment options and outcomes over time. A retrospective study of patients with spinal MGCT who were surgically treated in our center between 2006 and 2012 was performed. Overall, three surgical management strategies, including subtotal resection, piecemeal total resection, and total en bloc spondylectomy were applied. Postoperative radiotherapy was carried out in 4 cases. Clinical data and efficacy of surgical treatment strategy were analyzed via chart review. A total of 14 patients with spinal MGCT were included in the study. Three cases were diagnosed as primary MGCT (PMGCT), while the other 11 patients were secondary MGCT (SMGCT). The mean follow-up period was 41 (range 3–75) months. Recurrence was found in 7 patients after surgery in our center, while distant metastasis and death occurred in 4 and 6 cases, respectively. MGCT of bone is always a high-grade sarcoma with a poor prognosis and complete excision, while also preserving neural function, is recommended. In our study, patients who underwent total en bloc spondylectomy had significantly lower local recurrence rate for MGCT in the spine.
Similar content being viewed by others
References
Xu W, Li X, Huang W et al (2013) Factors affecting prognosis of patients with giant cell tumors of the mobile spine: retrospective analysis of 102 patients in a single center. Ann Surg Oncol 20(3):804–810
Wu Z, Yin H, Liu T et al (2014) MiR-126-5p regulates osteoclast differentiation and bone resorption in giant cell tumor through inhibition of MMP-13. Biochem Biophys Res Commun 443(3):944–949
Werner M (2006) Giant cell tumour of bone: morphological, biological and histogenetical aspects. Int Orthop 30(6):484–489
Junming M, Cheng Y, Dong C et al (2008) Giant cell tumor of the cervical spine: a series of 22 cases and outcomes. Spine (Phila Pa 1976) 33(3):280–288
Wu Z, Yang X, Xiao J et al (2011) Aneurysmal bone cyst secondary to giant cell tumor of the mobile spine: a report of 11 cases. Spine (Phila Pa 1976) 36(21):E1385–E1390
Rock MG, Sim FH, Unni KK et al (1986) Secondary malignant giant-cell tumor of bone. Clinicopathological assessment of nineteen patients. J Bone Jt Surg Am 68(7):1073–1079
Bertoni F, Bacchini P, Staals EL (2003) Malignancy in giant cell tumor of bone. Cancer 97(10):2520–2529
Dahlin DC, Cupps RE, Johnson EW Jr (1970) Giant-cell tumor: a study of 195 cases. Cancer 25(5):1061–1070
Reid R, Banerjee SS, Sciot R (2002) Giant cell tumour. In: Fletcher CDM, Unni KK, Mertens F (eds) World health organization classification of tumours: pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon, pp 309–314
Domovitov SV, Healey JH (2010) Primary malignant giant-cell tumor of bone has high survival rate. Ann Surg Oncol 17(3):694–701
Gong L, Liu W, Sun X et al (2012) Histological and clinical characteristics of malignant giant cell tumor of bone. Virchows Arch 460(3):327–334
Sakkers RJ, van der Heul RO, Kroon HM et al (1997) Late malignant transformation of a benign giant-cell tumor of bone. A case report. J Bone Jt Surg Am 79(2):259–262
Mori Y, Tsuchiya H, Karita M et al (2000) Malignant transformation of a giant cell tumor 25 years after initial treatment. Clin Orthop Relat Res 381:185–191
Marui T, Yamamoto T, Yoshihara H et al (2001) De novo malignant transformation of giant cell tumor of bone. Skelet Radiol 30(2):104–108
Unni KK (1996) Dahlin’s bone tumors-general aspects and data on 11,087 cases, 5th edn. Lippincott-Raven Publishers, Philadelphia, pp 263–287
Hutter RV, Worcester JN Jr, Francis KC et al (1962) Benign and malignant giant cell tumors of bone. A clinicopathological analysis of the natural history of the disease. Cancer 15:653–690
Frankel HL, Hancock DO, Hyslop G et al (1969) The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia, I. Paraplegia 7(3):179–192
Enneking WF (1986) A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res 204:9–24
Boriani S, Weinstein JN, Biagini R (1997) Primary bone tumors of the spine. Terminology and surgical staging. Spine (Phila Pa 1976) 22(9):1036–1044
Yin H, Zhou W, Meng J et al (2014) Prognostic factors of patients with spinal chondrosarcoma: a retrospective analysis of 98 consecutive patients in a single center. Ann Surg Oncol 21:3572–3578
Yin H, Zhou W, Yu H et al (2014) Clinical characteristics and treatment options for two types of osteoblastoma in the mobile spine: a retrospective study of 32 cases and outcomes. Eur Spine J 23(2):411–416
Yin H, Zhang D, Wu Z et al (2013) Desmoplastic fibroma of the spine: a series of 12 cases and outcomes. Spine J. doi:10.1016/j.spinee.2013.09.042
Boriani S, Sudanese A, Baldini N et al (1986) Sarcomatous degeneration of giant cell tumours. Ital J Orthop Traumatol 12(2):191–199
Gitelis S, Wang JW, Quast M et al (1989) Recurrence of a giant-cell tumor with malignant transformation to a fibrosarcoma twenty-five years after primary treatment. A case report. J Bone Jt Surg Am 71(5):757–761
Kenan S, Abdelwahab IF, Klein MJ et al (1995) Case report 863. Osteosarcoma associated with giant cell tumor. Skelet Radiol 24(1):55–58
Ortiz-Cruz EJ, Quinn RH, Fanburg JC et al (1995) Late development of a malignant fibrous histiocytoma at the site of a giant cell tumor. Clin Orthop Relat Res 318:199–204
Zhu XZ, Steiner GC (1990) Malignant giant cell tumor of bone: malignant transformation of a benign giant cell tumor treated by surgery. Bull Hosp Jt Dis Orthop Inst 50(2):169–176
Sanerkin NG (1980) Malignancy, aggressiveness, and recurrence in giant cell tumor of bone. Cancer 46(7):1641–1649
Nascimento AG, Huvos AG, Marcove RC (1979) Primary malignant giant cell tumor of bone: a study of eight cases and review of the literature. Cancer 44(4):1393–1402
Rao G, Suki D, Chakrabarti I et al (2008) Surgical management of primary and metastatic sarcoma of the mobile spine. J Neurosurg Spine 9(2):120–128
Mendenhall WM, Zlotecki RA, Scarborough MT et al (2006) Giant cell tumor of bone. Am J Clin Oncol 29(1):96–99
Beebe-Dimmer JL, Cetin K, Fryzek JP et al (2009) The epidemiology of malignant giant cell tumors of bone: an analysis of data from the Surveillance, Epidemiology and End Results Program (1975–2004). Rare Tumors 1(2):e52
Boriani S, Bandiera S, Donthineni R et al (2010) Morbidity of en bloc resections in the spine. Eur Spine J 19(2):231–241
Bandiera S, Boriani S, Donthineni R et al (2009) Complications of en bloc resections in the spine. Orthop Clin North Am 40(1):125–131
McDonnell MF, Glassman SD, Dimar JR 2nd et al (1996) Perioperative complications of anterior procedures on the spine. J Bone Jt Surg Am 78(6):839–847
Karamanakos PN, Jaaskelainen JE, Alafuzoff I et al (2010) Malignant giant cell tumor in the posterior fossa of a neonate. J Neurosurg Pediatr 5(3):277–282
Sasagawa Y, Tachibana O, Shiraga S et al (2012) Secondary malignant giant cell tumor of the clivus: case report. Clin Neurol Neurosurg 114(6):786–788
Kishima H, Miyao Y, Shimizu K (2001) Radiosensitive giant cell tumour of the sphenoid bone. Br J Neurosurg 15(2):171–174
Martins AN, Dean DF (1974) Giant cell tumor of sphenoid bone: malignant transformation following radiotherapy. Surg Neurol 2(2):105–107
Watkins LD, Uttley D, Archer DJ et al (1992) Giant cell tumors of the sphenoid bone. Neurosurgery 30(4):576–581
Yamamoto M, Fukushima T, Sakamoto S et al (1998) Giant cell tumor of the sphenoid bone: long-term follow-up of two cases after chemotherapy. Surg Neurol 49(5):547–552
Anract P, De Pinieux G, Cottias P et al (1998) Malignant giant-cell tumours of bone. Clinico-pathological types and prognosis: a review of 29 cases. Int Orthop 22(1):19–26
Mahadevan A, Miksad R, Goldstein M et al (2011) Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer. Int J Radiat Oncol Biol Phys 81(4):e615–e622
Campanacci M, Baldini N, Boriani S, Sudanese A (1987) Giant-cell tumor of bone. J Bone Jt Surg Am 69(1):106–114
Acknowledgments
This work was supported by the National Natural Science Foundation of China (81402222, 81402223, 81401355).
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Huabin Yin, Mo Cheng, and Bo Li contributed equally to this work, and all should be considered first author.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Yin, H., Cheng, M., Li, B. et al. Treatment and outcome of malignant giant cell tumor in the spine. J Neurooncol 124, 275–281 (2015). https://doi.org/10.1007/s11060-015-1835-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-015-1835-9